Mammalian Target of Rapamycin Controls Dendritic Cell Development Downstream of Flt3 Ligand Signaling
- 7 October 2010
- Vol. 33 (4), 597-606
- https://doi.org/10.1016/j.immuni.2010.09.012
Abstract
No abstract availableKeywords
Funding Information
- American Asthma Foundation
- National Institutes of Health (AI057229, AI067804, AI072571, HHSN272200700038C)
This publication has 61 references indexed in Scilit:
- Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cellsProceedings of the National Academy of Sciences, 2010
- Origin of the Lamina Propria Dendritic Cell NetworkImmunity, 2009
- Immunoregulatory functions of mTOR inhibitionNature Reviews Immunology, 2009
- The cellular niche of Listeria monocytogenes infection changes rapidly in the spleenEuropean Journal of Immunology, 2009
- Transcription Factor E2-2 Is an Essential and Specific Regulator of Plasmacytoid Dendritic Cell DevelopmentCell, 2008
- The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissuesNature Immunology, 2008
- Division of labor, plasticity, and crosstalk between dendritic cell subsetsCurrent Opinion in Immunology, 2007
- Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrowNature Immunology, 2007
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- Intrasplenic steady-state dendritic cell precursors that are distinct from monocytesNature Immunology, 2006